☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
molnupiravir
Merck and Ridgeback Present Results of Molnupiravir in P-III MOVe-OUT Trial for the Treatment of COVID-19 at ASTMH 2021
November 17, 2021
Merck Reports the Initiation of Rolling Submission to Health Canada for Molnupiravir to Treat COVID-19
August 16, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.